Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : sciclone pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Skywatcher who wrote (461)	3/17/2000 12:14:00 PM
From: Guy Gordon	Read Replies (1) \| Respond to of 1137

Could someone please assuage my ignorance? As far as I can tell, ZADAXIN is not approved for any use in the USA, right? The March 17 news is for Thailand, Laos and Malta. The Yahoo profile says: "The Company's ZADAXIN is approved for marketing in 13 countries including Argentina, Cambodia, Italy, Kuwait, Mexico, Myanmar, Pakistan, the People's Republic of China, Peru, the Philippines, Singapore, Venezuela and Vietnam." That's 16 countries and the press release says 19. Here's a Jan 27 article that says 15 countries biz.yahoo.com and talks about Phase 2 & 3 trials for drug combo's with Zadxin. As far as I can tell, Italy is the only European country where you can get it. (I was lead to SciClone by a recent newspaper article about a Doctor who flew to Italy to get it for himself.) Can anyone fill me in here? What I'm after is, what are the current sales to the Western World, and can we expect a large rise in the near future? My appologies if this has already been discussed here. I'll read the back-thread as soon as I can find the time.